[go: up one dir, main page]

PE27399A1 - Uso del acido 2-(3,4-dimetoxicinamoil) aminobenzoico para elaborar un medicamento para el tratamiento o prevencion de la restenosis - Google Patents

Uso del acido 2-(3,4-dimetoxicinamoil) aminobenzoico para elaborar un medicamento para el tratamiento o prevencion de la restenosis

Info

Publication number
PE27399A1
PE27399A1 PE1997001173A PE00117397A PE27399A1 PE 27399 A1 PE27399 A1 PE 27399A1 PE 1997001173 A PE1997001173 A PE 1997001173A PE 00117397 A PE00117397 A PE 00117397A PE 27399 A1 PE27399 A1 PE 27399A1
Authority
PE
Peru
Prior art keywords
dimetoxicinamoil
prevention
prepare
restenosis
aminobenzoic
Prior art date
Application number
PE1997001173A
Other languages
English (en)
Inventor
Juichi Fukuyama
Keiji Miyazawa
Shuichiro Hamano
Arao Ujiie
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25101171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE27399(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE27399A1 publication Critical patent/PE27399A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE AL USO DEL ACIDO 2-(3,4-DIMETOXICINAMOIL)-AMINOBENZOICO PARA ELABORAR UNA COMPOSICION QUE SE ADMINISTRA DESPUES DE UNA INTERVENCION QUIRURGICA CORONARIA TAL COMO ANGIOPLASTIA CORONARIA PERCUTANEA TRANSLUMINAL, ATERECTOMIA DE DIRECCION CORONARIA, STENT, ENTRE OTROS; PARA LA PREVENCION DE LA PROLIFERACION EXCESIVA DE CELULAS VASCULARES DE MUSCULOS BLANDOS (VSMC) QUE APARECE EN UNA ETAPA TEMPRANA DESPUES DE UNA INTERVENCION QUIRURGICA CORONARIA, PROVOCANDO RESTENOSIS
PE1997001173A 1996-12-30 1997-12-29 Uso del acido 2-(3,4-dimetoxicinamoil) aminobenzoico para elaborar un medicamento para el tratamiento o prevencion de la restenosis PE27399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/774,418 US6019104A (en) 1996-12-30 1996-12-30 Method for the treatment or prevention of restenosis associated with coronary intervention

Publications (1)

Publication Number Publication Date
PE27399A1 true PE27399A1 (es) 1999-03-31

Family

ID=25101171

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997001173A PE27399A1 (es) 1996-12-30 1997-12-29 Uso del acido 2-(3,4-dimetoxicinamoil) aminobenzoico para elaborar un medicamento para el tratamiento o prevencion de la restenosis

Country Status (19)

Country Link
US (1) US6019104A (es)
EP (1) EP0891185A2 (es)
KR (1) KR19990087396A (es)
CN (1) CN1220599A (es)
AR (1) AR009446A1 (es)
AU (1) AU7854198A (es)
BR (1) BR9707877A (es)
CA (1) CA2247306A1 (es)
CZ (1) CZ251198A3 (es)
EA (1) EA001931B1 (es)
HU (1) HUP9904029A3 (es)
ID (1) ID20165A (es)
IL (1) IL125660A0 (es)
NO (1) NO983947D0 (es)
NZ (1) NZ331338A (es)
PE (1) PE27399A1 (es)
TR (1) TR199801698T1 (es)
WO (1) WO1998029104A2 (es)
ZA (1) ZA9711719B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE358456T1 (de) * 1998-05-05 2007-04-15 Boston Scient Ltd Stent mit glatten enden
JP2002536326A (ja) * 1999-02-03 2002-10-29 スミスクライン・ビーチャム・コーポレイション 冠状動脈インターベンションに伴う心臓血管事象の予防または軽減方法
WO2000045811A1 (en) * 1999-02-03 2000-08-10 Smithkline Beecham Corporation Method for the prevention or reduction of cariovascular events associated with coronary intervention
WO2001062241A1 (en) * 2000-02-23 2001-08-30 Smithkline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640710B2 (es) * 1973-01-18 1981-09-22
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Also Published As

Publication number Publication date
KR19990087396A (ko) 1999-12-27
EA001931B1 (ru) 2001-10-22
US6019104A (en) 2000-02-01
IL125660A0 (en) 1999-04-11
CN1220599A (zh) 1999-06-23
BR9707877A (pt) 1999-07-27
CA2247306A1 (en) 1998-07-09
HUP9904029A3 (en) 2000-11-28
AU7854198A (en) 1998-07-31
HUP9904029A2 (hu) 2000-05-28
AR009446A1 (es) 2000-04-12
WO1998029104A3 (en) 1998-10-01
EA199800781A1 (ru) 1999-12-29
WO1998029104A2 (en) 1998-07-09
NZ331338A (en) 2000-12-22
NO983947D0 (no) 1998-08-27
ZA9711719B (en) 1998-06-25
ID20165A (id) 1998-10-15
CZ251198A3 (cs) 1999-08-11
EP0891185A2 (en) 1999-01-20
TR199801698T1 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
ES2144792T3 (es) Uso de inhibidores de la nadph oxidasa para la preparacion de un medicamento para la prevencion de la aterosclerosis.
ES2162908T3 (es) Derivados de la proteina-1 quimioatractora de monocitos (mcp-1) humana.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2136618T3 (es) Cicatrizacion de heridas.
ES2080837T3 (es) Tratamiento de estados y enfermedades.
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
BR9913153A (pt) Normalização da atividade do substrato
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
MX9300977A (es) Compuetos heterobiciclicos.
NZ515705A (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) alpha
ITPD910032A1 (it) Canali di guida biodegradabili e bioassorbibili da impiegare per la rigenerazione nervosa.
ES8103162A1 (es) Un procedimiento para la preparacion de interferon tipo ii.
AR013873A1 (es) Una composicion que comprende derivados de tetralina y factores ico neurologicos para estimular el crecimiento de neuritas en celulas nerviosas
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
PT90478A (pt) Processo para a preparacao de derivados da purina e de composicoes farmaceuticas que os contem
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
SE9403158D0 (sv) New use of prostaglandins
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
EP0474517A3 (en) Novel use of 1alpha-hydroxylated-19-nor-vitamin d compounds to treat psoriasis
PE27399A1 (es) Uso del acido 2-(3,4-dimetoxicinamoil) aminobenzoico para elaborar un medicamento para el tratamiento o prevencion de la restenosis
UY26951A1 (es) Derivados de ácido propiónico
AR026257A1 (es) N-guanidinoalquilamidas, su preparacion, su uso y composiciones farmaceuticas que las contienen
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación

Legal Events

Date Code Title Description
FC Refusal